IQUIMEFA   05518
INSTITUTO QUIMICA Y METABOLISMO DEL FARMACO
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
TNFá and a fraction purified from Larrea divaricata Cav.: a novel immunomodulatory treatment against Candida albicans infection.
Autor/es:
MARTINO, RENZO; DAVICINO, ROBERTO; MATTAR, AIDA; CASALI, YOLANDA; MICALIZZI, BLAS.
Lugar:
Buenos Aires
Reunión:
Congreso; LVIII Reunión Sociedad Argentina de Inmunología; 2010
Institución organizadora:
Sociedad Argentina de Inmunología
Resumen:
Larrea divaricata is a burst with several applications in argentinean
folk medicine. The aim of this work was test an alternative
phytotherapy treatment against Candida albicans infection
by enhancing the activity of murine macrophages (MO). In this
work healthy and infected mice were used and the following
groups were test in agreement with the treatment: a) PBS
(control group); b) fraction obtained from L. divaricata (F1); c)
TNFá; d) antibody against dectin-1(15Y9), which is a blocker of
â-glucans receptor; e) F1+TNFá; f) F1+15Y9; g) TNFá+15Y9 and
h) F1+TNFá+15Y9. Treatments were started 24h after infection
and were administered once a day during 3 days. MO were harvested,
and organs (liver, spleen and kidney) and serum were
extracted. Phagocytosis activity, superoxide production by NBT
test, Nitric oxide (NO) levels, acid phosphatase activity and viability
by MTT test were performed to determinate MO activity.
The colony forming units (CFU) were counted in organs
homogenates and serum TNFá, IL-10 and NO were determined.
Results showed that F1 increase phagocytosis in both: healthy
and infected mice (p<0.05). The NO was increased in culture supernatants
and serum (p<0.05) of infected mice treated with (e)
procedure. This treatment also showed the highest increase of
reduced NBT (p<0.01) and acid phosphatase activity (p<0.05).
Serum from infected mice showed that F1 increased TNFá production
(p<0.05), but IL-10 was not modified. Infection was eliminated
from liver and kidney in mice treated with F1 (p<0.01).
When treatment (e) was tested the infection of the three study
organs was eliminated (p<0.05). The mice treated with 15Y9 did
not show any signs of MO activation or clearance of the infection.
We suggest that the pathogen is eliminated through the
activation of the innate immune system and we could observe a
synergistic effect between F1 and TNFá treatment. We propose
that the use of F1 and TNFá could be a valuable treatment for
C. albicans infection.